Key facts
- This page summarizes Robert Renninger's Form 4 filing for LeonaBio, Inc. (LONA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 13 Apr 2026, 16:47.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The shares subject to the option shall be scheduled to vest monthly over a term of 48 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates.